Cash on Hand for Align Technology (ALGN)
According to Align Technology's latest reported financial statements, the company's latest reported cash and short-term investments is $1.09B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
ALGN
Currently viewingCash on HandSwitch metric
Latest period
$1.09B
YoY change
+4.9%
5Y CAGR
+2.6%
Peak year (2021)
$1.17B
Latest annual
$1.09B
Cash on Hand history chart for Align Technology (ALGN) from 1999 to 2025
Cash on Hand history table for Align Technology (ALGN) from 1999 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $1.09B | +4.9% | ||
| 2024 | $1.04B | +7.3% | ||
| 2023 | $972.74M | -2.7% | ||
| 2022 | $999.58M | -14.7% | ||
| 2021 | $1.17B | +21.9% | ||
| 2020 | $960.84M | +10.6% | ||
| 2019 | $868.63M | +18.1% | ||
| 2018 | $735.36M | +1.9% | ||
| 2017 | $721.54M | +12.7% | ||
| 2016 | $640.26M | +21.4% | ||
| 2015 | $527.29M | +16.0% | ||
| 2014 | $454.66M | +22.9% | ||
| 2013 | $369.99M | +10.5% | ||
| 2012 | $334.87M | +35.0% | ||
| 2011 | $248.07M | -18.2% | ||
| 2010 | $303.28M | +62.6% | ||
| 2009 | $186.47M | +69.3% | ||
| 2008 | $110.17M | -13.9% | ||
| 2007 | $127.89M | +99.7% | ||
| 2006 | $64.04M | -13.7% | ||
| 2005 | $74.22M | +6.5% | ||
| 2004 | $69.66M | +47.5% | ||
| 2003 | $47.23M | +23.5% | ||
| 2002 | $38.24M | -39.3% | ||
| 2001 | $63.04M | +405.9% | ||
| 2000 | $12.46M | +3.1% | ||
| 1999 | $12.09M | — |
Cash on Hand values are taken from Align Technology's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual cash and short-term investments for Align Technology (ALGN) came in at $1.09B – edged up 4.9% year-over-year.
Align Technology cash and short-term investments has grown for 2 consecutive years, with a +2.6% compound annual growth rate over 2020–2025 (5 years).
Align Technology cash and short-term investments declined from $1.17B in 2021 to $1.09B in 2025, a 6.5% drawdown.
Across the available history, cash and short-term investments reached its high of $1.17B in 2021 and its low of $12.09M in 1999.
Align Technology (ALGN) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $11.85B.
Align Technology Cash on Hand by Year
Align Technology Cash on Hand 2025: $1.09B
Align Technology cash and short-term investments in 2025 was $1.09B, edged up 4.9% from 2024.
Align Technology Cash on Hand 2024: $1.04B
Align Technology cash and short-term investments in 2024 was $1.04B, grew 7.3% from 2023.
Align Technology Cash on Hand 2023: $972.74M
Align Technology cash and short-term investments in 2023 was $972.74M, edged down 2.7% below 2022.
Align Technology Cash on Hand 2022: $999.58M
Align Technology cash and short-term investments in 2022 was $999.58M, declined 14.7% below 2021.
Align Technology Cash on Hand 2021: $1.17B
Align Technology cash and short-term investments in 2021 was $1.17B.
See more financial history for Align Technology (ALGN).
Sector peers — Cash on Hand
Companies in the same sector as Align Technology, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Novo Nordisk A/S (NVO) | $26.96B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Align Technology's cash and short-term investments?
- Latest reported cash and short-term investments for Align Technology (ALGN) is $1.09B (period ending December 31, 2025).
How has Align Technology cash and short-term investments changed year-over-year?
- Align Technology (ALGN) cash and short-term investments changed +4.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Align Technology cash and short-term investments?
- Align Technology (ALGN) cash and short-term investments compound annual growth rate is +2.6% over the most recent 5 years available.
When did Align Technology cash and short-term investments hit its highest annual value?
- Align Technology cash and short-term investments reached its highest annual value of $1.17B in 2021.
What was Align Technology cash and short-term investments in 2024?
- Align Technology (ALGN) cash and short-term investments in 2024 was $1.04B.
What was Align Technology cash and short-term investments in 2025?
- Align Technology (ALGN) cash and short-term investments in 2025 was $1.09B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
ALGN Overview
Company profile, financial tools, and key metrics
ALGN Revenue Counter
Earns $127.95 every second. See per minute, hour, and day.
ALGN Earnings Counter
Earns $13.01 per second net profit. See per minute, hour, and day.
ALGN Economic Scale
Exceeds Curacao's GDP. Compare with world economies.
ALGN What If Invested
What if you had invested $1,000? See historical returns from any date.
ALGN How It Makes Money
Discover visual breakdown of $4.03B in revenue — where it comes from and where it goes.
ALGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
ALGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
ALGN Daily Price Character
Explosive · 49.8% historical win rate (green days). Streaks & record days.
ALGN Buybacks
3.49% TTM buyback yield. Shareholder yield & SBC comparison.